Baker McKenzie advised Danish biotechnology company Novonesis on its acquisition of dsm-firmenich’s share in the Feed Enzyme Alliance. The context Novonesis is a global biotechnology company with headquarters in Bagsværd, just outside Copenaghen,
Bär & Karrer advised the selling shareholders of Zwei Wealth Experts in connection with Swiss Life’s acquisition of their company. The context Zwei Wealth is a Swiss asset management advisory firm with
Pestalozzi advised insurance company Swiss Life through its acquisition of Swiss advisory firm Zwei Wealth. The context Headquartered in Zurich, Swiss life is an insurance multinational, offering comprehensive life and pensions and financial solutions, directed
Niederer Kraft Frey (NKF) advised Largo Films, a data-driven moviemaking company, throughout its Series A financing round. Californian firms TI Capital Management and QBIT Global Ventures Fund co-led the seed capital round in question. Hollywood
Homburger advised vacation rental platform HomeToGo on its acquisition of Swiss vacation rental management company Interhome. The context Listed on the Frankfurt Stock Exchange, HomeToGo provides SaaS-supported marketplace for vacation rental solutions. In connection with
White & Case advised pharmaceutical multinational Takeda in connection with two distinct operations. The first matter sees Takeda involved as the seller of a pharmaceutical products portfolio, currently licensed to Hikma Pharmaceuticals. As a
Homburger advised Goldman Sachs International as part of the initial purchasers involved in the issuance of EUR 420 m Senior Secured Notes by Matterhorn Telecom. The firm also acted as Swiss counsel to Goldman Sachs International
Zurich-based MME advised private equity firm KKA Partners on its management buyout of Blackroll. Active across across Germany, Austria and Switzerland, KKA’s investment focus lays on medium sized businesses. In connection with the
Advestra advised Citigroup, UBS and Stifel Europe in connection with ther joint global coordination role in BioVersys’ IPO. The context BioVersys specialises in the identification, development and commercialization phases of novel antibacterial
Homburger advised Zürcher Kantonalbank (ZKB) as part of the joint lead management overseeing the successful issuance by Luzerner Kantonalbank (LUKB). ZKB acted as structuring advisor and joint-lead manager in connection with Luzerner Kantonalbank’s
